Xuli Meng

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Chronic Obstructive Pulmonary Disease

Cell Cycle Arrest

Positive Breast Cancer

Vascular Endothelial Growth Factor

Top Venues

Cancer biology & medicine

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jiancheng Mou, Chenhong Li, Qinghui Zheng, Xuli Meng, Hongchao Tang
Research progress in tumor angiogenesis and drug resistance in breast cancer. Cancer biology & medicine 21 (7) (2024)
Jiancheng Mou, Chenhong Li, Qinghui Zheng, Xuli Meng, Hongchao Tang
Research progress in tumor angiogenesis and drug resistance in breast cancer. Cancer biology & medicine 21 (7) (2024)
Jiancheng Mou, Chenhong Li, Qinghui Zheng, Xuli Meng, Hongchao Tang
Research progress in tumor angiogenesis and drug resistance in breast cancer. Cancer biology & medicine (2024)
Jiancheng Mou, Chenhong Li, Qinghui Zheng, Xuli Meng, Hongchao Tang
Research progress in tumor angiogenesis and drug resistance in breast cancer. Cancer biology & medicine 21 (7) (2024)
Yihao Wu, Tao Zhou, Da Qian, Xiaozhen Liu, Yuhao Xu, Weimin Hong, Xuli Meng, Hongchao Tang
Z-Guggulsterone Induces Cell Cycle Arrest and Apoptosis by Targeting the p53/CCNB1/PLK1 Pathway in Triple-Negative Breast Cancer. ACS omega 8 (2) (2023)
Yihao Wu, Tao Zhou, Da Qian, Xiaozhen Liu, Yuhao Xu, Weimin Hong, Xuli Meng, Hongchao Tang
Z-Guggulsterone Induces Cell Cycle Arrest and Apoptosis by Targeting the p53/CCNB1/PLK1 Pathway in Triple-Negative Breast Cancer. ACS omega 8 (2) (2023)
Jie Qiu, Yiwen Zheng, Da Qian, Dandan Guan, Qinghui Zheng, Yuhao Xu, Siyi Ju, Xuli Meng, Hongchao Tang
Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real-World Data. Journal of oncology 2022 (2022)
Jie Qiu, Yiwen Zheng, Da Qian, Dandan Guan, Qinghui Zheng, Yuhao Xu, Siyi Ju, Xuli Meng, Hongchao Tang
Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real-World Data. Journal of oncology 2022 (2022)